XOMA | XOMA Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	26.54 - 27.50
52 Week Range	18.95 - 35.00
Beta	0.92
Implied Volatility	118.03%
IV Rank	48.90%
Day's Volume	46,007
Average Volume	32,733
Shares Outstanding	11,782,700
Market Cap	317,897,246
Sector	Healthcare
Industry	Biotechnology
IPO Date	1986-06-06

Valuation
Profitability
Growth
Health
P/E Ratio	-8.79
Forward P/E Ratio	-33.19
EPS	-3.07
1YR Price Target	62.50
Dividend Yield	8.06%
Dividend Per Share	2.17
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	13
Country	USA
Website	XOMA

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

XOMA's peers: SVRA, VINC, HOWL, EWTX, DBTX, CELC, CCCC, THRD, PASG, ACRV, ELYM, TCON, RZLT, SIOX, STOK, CRNX, DYN, RVMD, DSGN, TNGX, TALS, ACHL

*Chart delayed

Analyzing fundamentals for XOMA we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is on medium level and Health is very weak. For more detailed analysis please see XOMA Fundamentals page.

Watching at XOMA technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on XOMA Technicals page.